The study conducted by Darabi et al. found that serum visfatin was significantly higher in acute coronary syndrome patients than the stable CAD patients [22], indicating that visfatin might play an important part in the plaque instability and inflammation of coronary atherosclerosis. This evidence concerns the gene NAMPT and coronary artery disorder.